Free Trial

Pro-Dex (PDEX) Competitors

Pro-Dex logo
$47.63 +2.42 (+5.35%)
(As of 11/20/2024 ET)

PDEX vs. XAIR, DRIO, STIM, PAVM, TTOO, KIDS, AXGN, SIBN, TMCI, and CATX

Should you be buying Pro-Dex stock or one of its competitors? The main competitors of Pro-Dex include Beyond Air (XAIR), DarioHealth (DRIO), Neuronetics (STIM), PAVmed (PAVM), T2 Biosystems (TTOO), OrthoPediatrics (KIDS), AxoGen (AXGN), SI-BONE (SIBN), Treace Medical Concepts (TMCI), and Perspective Therapeutics (CATX). These companies are all part of the "medical equipment" industry.

Pro-Dex vs.

Beyond Air (NASDAQ:XAIR) and Pro-Dex (NASDAQ:PDEX) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, earnings, media sentiment, institutional ownership, community ranking and risk.

In the previous week, Beyond Air had 5 more articles in the media than Pro-Dex. MarketBeat recorded 5 mentions for Beyond Air and 0 mentions for Pro-Dex. Beyond Air's average media sentiment score of 0.55 beat Pro-Dex's score of 0.00 indicating that Beyond Air is being referred to more favorably in the media.

Company Overall Sentiment
Beyond Air Positive
Pro-Dex Neutral

Pro-Dex has higher revenue and earnings than Beyond Air. Beyond Air is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Beyond Air$1.16M30.59-$60.24M-$1.41-0.35
Pro-Dex$53.84M2.88$2.13M$1.5430.93

Beyond Air currently has a consensus price target of $3.67, indicating a potential upside of 645.86%. Pro-Dex has a consensus price target of $52.00, indicating a potential upside of 9.17%. Given Beyond Air's higher probable upside, equities research analysts clearly believe Beyond Air is more favorable than Pro-Dex.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Beyond Air
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.00
Pro-Dex
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Beyond Air has a beta of -0.18, meaning that its share price is 118% less volatile than the S&P 500. Comparatively, Pro-Dex has a beta of 0.39, meaning that its share price is 61% less volatile than the S&P 500.

Pro-Dex received 104 more outperform votes than Beyond Air when rated by MarketBeat users. However, 69.57% of users gave Beyond Air an outperform vote while only 61.54% of users gave Pro-Dex an outperform vote.

CompanyUnderperformOutperform
Beyond AirOutperform Votes
48
69.57%
Underperform Votes
21
30.43%
Pro-DexOutperform Votes
152
61.54%
Underperform Votes
95
38.46%

31.5% of Beyond Air shares are held by institutional investors. Comparatively, 15.3% of Pro-Dex shares are held by institutional investors. 20.1% of Beyond Air shares are held by insiders. Comparatively, 47.5% of Pro-Dex shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Pro-Dex has a net margin of 9.17% compared to Beyond Air's net margin of -2,369.17%. Pro-Dex's return on equity of 16.74% beat Beyond Air's return on equity.

Company Net Margins Return on Equity Return on Assets
Beyond Air-2,369.17% -227.29% -106.51%
Pro-Dex 9.17%16.74%9.98%

Summary

Pro-Dex beats Beyond Air on 10 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PDEX vs. The Competition

MetricPro-DexSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$147.35M$4.47B$5.07B$8.90B
Dividend YieldN/A36.79%4.99%4.07%
P/E Ratio30.9313.2787.8613.46
Price / Sales2.8844.831,228.8287.66
Price / Cash47.2152.2739.5136.27
Price / Book5.035.776.946.30
Net Income$2.13M$13.76M$119.12M$225.93M
7 Day Performance-0.38%-1.10%-1.84%-1.32%
1 Month Performance67.48%0.56%-3.65%0.60%
1 Year Performance172.02%50.90%31.64%26.23%

Pro-Dex Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PDEX
Pro-Dex
1.5482 of 5 stars
$47.63
+5.4%
$52.00
+9.2%
+174.5%$147.35M$53.84M30.93140
XAIR
Beyond Air
4.2935 of 5 stars
$0.49
-5.8%
$3.67
+645.9%
-69.1%$37.87M$1.16M0.0070Gap Down
DRIO
DarioHealth
1.8695 of 5 stars
$0.78
-1.3%
$4.00
+412.8%
-31.6%$26.94M$20.35M-0.83200
STIM
Neuronetics
2.3981 of 5 stars
$0.80
+6.6%
$4.67
+481.5%
-40.6%$22.92M$71.35M0.00180
PAVM
PAVmed
3.9879 of 5 stars
$1.03
+1.0%
$21.00
+1,938.8%
-68.7%$11.29M$2.45M-0.2490Gap Down
TTOO
T2 Biosystems
2.4481 of 5 stars
$0.46
-4.2%
$5.00
+982.7%
-88.3%$10.16M$7.19M0.00180
KIDS
OrthoPediatrics
4.0997 of 5 stars
$25.50
+4.9%
$40.00
+56.9%
-19.9%$588.93M$148.73M-20.73200
AXGN
AxoGen
2.7099 of 5 stars
$12.90
+1.2%
$15.00
+16.3%
+113.2%$561.10M$159.01M0.00426
SIBN
SI-BONE
4.3736 of 5 stars
$12.15
-1.4%
$23.00
+89.3%
-32.6%$516.68M$138.89M0.00350Analyst Forecast
Insider Trade
Analyst Revision
TMCI
Treace Medical Concepts
1.0224 of 5 stars
$7.98
+2.8%
$7.40
-7.3%
-7.1%$483.42M$187.12M0.00250
CATX
Perspective Therapeutics
2.7597 of 5 stars
$6.16
-9.1%
$21.57
+250.2%
N/A$458.24M$1.43M0.00116Analyst Revision

Related Companies and Tools


This page (NASDAQ:PDEX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners